Healthicare review
Oral breaks the pattern
$174 a month for the semaglutide injection, $147.90 on the quarterly plan — and an oral line that steps from $149.99 to $249.99 in month two.
Our verdict
The injectable half of Healthicare is priced the way a buyer would want everything priced: one figure per drug, unchanged by dose, with the quarterly charge printed beside the monthly rate. The oral semaglutide is built the other way around. $149.99 is a first month carrying $100 off, and the standing rate behind it is $249.99, a 67% step up on the second invoice. The two halves of this catalog do not behave alike.
Disclosure: GLP Loss is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
At a glance
- Category
- compounded semaglutide
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection · Oral
- Dose pricing
- Flat across doses
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
- Pharmacy
- Not named
- Updated
- September 2026
What it is
A telehealth seller of compounded semaglutide and tirzepatide, with the injectables priced flat across every dose and the oral semaglutide sold behind a discounted first month.
How it works
A monthly charge or a three-month plan on each injectable, with the three-month option published as both a per-month rate and a billed total. Dose does not move the injectable figure. No state list is published.
Pricing transparency
Injectable semaglutide is $174 billed monthly, or $147.90 a month on the three-month plan, charged as $443.70 every three months. Injectable tirzepatide is $264 monthly, or $224.40 on the quarterly plan at $673.20 a charge. Oral semaglutide is $149.99 for a first month, $100 off, then $249.99 a month.
Branded vs compounded
An injectable and an oral compounded semaglutide, plus compounded tirzepatide by injection. Compounded drugs are not FDA-approved and are not reviewed by the FDA for safety, efficacy or quality before dispensing.
Pros and watch-outs
What we like
- Injectable prices hold flat as the dose climbs
- The quarterly plan publishes its billed total
- $147.90 is stated to the cent, not rounded
- Both injectable molecules carry a complete figure
Watch-outs
- Oral semaglutide rises 67% after the first month
- The $100 oral discount applies once
- No quarterly plan is published for the oral
- No state list is published
Best for
Buyers on an injectable who will take the quarterly plan.
Who should look elsewhere
Anyone budgeting the oral from its first-month figure.
How Healthicare compares
A few alternatives worth a look, depending on what you’re optimizing for.
- SkinnyRx
A discounted rate, if it lasts
See SkinnyRx → - Bodybuilding Health+
A headline that is the month-to-month rate
See Bodybuilding Health+ → - Oak
Flat dose pricing without a subscription
See Oak →
More compounded semaglutide sellers reviews: Ivy RxJune HealthKERNX HealthKin MedsLean MedsLifeMD
Evidence & trials · Reviewed and last verified September 2026
How we assessed this. This review reflects GLP Loss’s own read of Healthicare’s publicly-stated model — pricing transparency, clinical oversight, medication clarity, and access — against our editorial methodology. We publish no fabricated ratings or first-hand outcomes. A partnership never changes the assessment — see how we make money.
Frequently asked
- What does Healthicare charge for injectable semaglutide?
- $174 a month billed monthly, or $147.90 a month on the three-month plan. That plan lands as $443.70 every three months, which is the figure a card actually sees. Dose does not change it.
- Why does the oral price jump in month two?
- The $149.99 entry is a single month with $100 taken off. Behind it stands $249.99, so the second invoice is $100 higher than the first. That is a 67% increase, and $249.99 is the figure worth budgeting against.
- How much is tirzepatide here?
- $264 a month billed monthly, or $224.40 a month on the three-month plan, charged as $673.20. Like the semaglutide injection, it holds flat across doses, so titration does not move the bill.
- Does the quarterly plan save money?
- Yes, by 15% on both injectables. A year of injectable semaglutide costs $2,088 billed monthly against $1,774.80 across four quarterly charges. Tirzepatide comes to $3,168 against $2,692.80.
- Is Healthicare expensive compared with other compounded semaglutide sellers providers?
- Healthicare publishes a starting figure of $174/mo. Across the 115 compounded semaglutide sellers providers we review that publish a single monthly figure, those run $76 to $369 with a median of $170, which puts Healthicare above the median. The other 5 compounded semaglutide sellers providers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.